1 - 10 of about 10

• 1.

  The Wnt/β-Catenin Inhibitor HC-1 Suppresses Liver Fibrosis by Inhibiting Activated Hepatic Stellate Cells and Inducing Matrix Metalloproteinase-1. , Hatakeyama D, Itaba N, Shimizu H, Morimoto M, Shiota G , Yonago Acta Med , vol.68 (p.131 - 143) , 2025 , The Multiple Authorship , English

• 2.

  Secreted matrix metalloproteinase-14 is a predictor for antifibrotic effect of IC-2-engineered mesenchymal stem cell sheets on liver fibrosis in mice. , Fukushima K, Itaba N, Kono Y, Okazaki S, Enokida S, Kuranobu N, Murakami J, Enokida M, Nagashima H, Kanzaki S, Namba N, Shiota G , Regen Ther , vol.18 (p.292 - 301) , 2021 , The Multiple Authorship , English

• 3.

  WNT/β-catenin Signal Inhibitor IC-2-derived Small-Molecule Compounds Suppress TGF-β1-induced Fibrogenic Response of Renal Epithelial Cells by Inhibiting SMAD2/3 Signalling. , Hoi S, Tsuchiya H, Itaba N, Suzuki K, Oka H, Morimoto M, Takata T, Isomoto H, and Shiota G , Clin Exp Pharmacol Physiol , vol.47 (p.940 - 946) , 2020 , There is Review , The Multiple Authorship , English

• 4.

  dentification of a Novel Deactivating Small-molecule Compound for Fibrogenic Hepatic Stellate Cells. , Sakaguchi T, Kono Y, Itaba N, Morimoto M, Isomoto H, and Shiota G. , Yonago Acta Med , vol.63 (p.79 - 87) , 2020 , There is Review , The Multiple Authorship , English

• 5.

  Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets. , Itaba N, Kono Y, Watanabe K, Yokobata T, Oka H, Osaki M, Kakuta H, Morimoto M, and Shiota G , Sci Rep , vol.9 (p.6841 - ) , 2019 , The Multiple Authorship , English

• 6.

  Hepatic cell sheets engineered from human mesenchymal stem cells with a single small molecule compound IC-2 ameliorate acute liver injury in mice. , Itaba N, Noda I, Oka H, Kono Y, Okinaka K, Yokobata T, Okazaki S, Morimoto M, and Shiota G , Regen Ther , vol.24 (p.45 - 57) , 2018 , The Multiple Authorship , English

• 7.

  A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells. , Seto K, Sakabe T, Itaba N, Azumi J, Oka H, Morimoto M, Umekita Y and Shiota G10. Seto K, Sakabe T, Itaba N, Azumi J, Oka H, Morimoto M, Umekita Y and Shiota G10. Seto K, Sakabe T, Itaba N, Azumi J, Oka H, Morimoto M, Umekita Y and Shiota G10. Seto K, Sakabe T, Itaba N, Azumi J, Oka H, Morimoto M, Umekita Y and Shiota G10. Seto K, Sakabe T, Itaba N, Azumi J, Oka H, Morimoto M, Umekita Y and Shiota G10. Seto K, Sakabe T, Itaba N, Azumi J, Oka H, Morimoto M, Umekita Y and Shiota G10. Seto K, Sakabe T, Itaba N, Azumi J, Oka H, Morimoto M, Umekita Y and Shiota G10. Seto K, Sakabe T, Itaba N, Azumi J, Oka H, Morimoto M, Umekita Y and Shiota G , Anticancer Res , vol.37 (p.3569 - 3579) , 2017 , There is Review , The Multiple Authorship , English

• 8.

  Wnt/β-Catenin Signal Inhibitor HC-1 Sensitizes Oral Squamous Cell Carcinoma Cells to 5-Fluorouracil through Reduction of CD44-Positive Population. , Yokogi S, Tsubota T, Kanki K, Azumi J, Itaba N, Oka H, Morimoto M, Ryoke K and Shiota G , Yonago Acta Med , vol.59 (p.93 - 99) , 2016 , There is Review , The Multiple Authorship , English

• 9.

  Human mesenchymal stem cell-engineered hepatic cell sheets accelerate liver regeneration in mice. , Itaba N, Matsumi Y, Okinaka K, Ashla A. A, Kono Y, Osaki M, Morimoto M, Sugiyama N, Ohashi K, Okano T and Shiota G , Sci Rep , vol.5 (p.16169 - ) , 2015 , The Multiple Authorship , English

• 10.

  Identification of the small molecule compound which induces hepatic differentiation of human mesenchymal stem cells. , taba N, Sakabe T, Kanki K, Azumi J, Shimizu H, Kono Y, Matsumi Y, Abe K, Tonoi T, Oka H, Sakurai T, Saimoto H, Morimoto M, Mabuchi Y, Matsuzaki Y and Shiota G , Regen Ther , vol.2 (p.32 - 41) , 2015 , There is Review , The Multiple Authorship , English

Page: [<<PREV] [1] [NEXT>>]